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Summary Crimean-Congo hemorrhagic fever (CCHF) is an acute, tick-borne viral disease,
affecting only humans and newborn mice, with hemorrhagic manifestations and considerable
mortality in humans. CCHF virus circulates in nature in an enzootic tick—vertebrate—tick cycle;
migrating birds and livestock transferred from endemic to non-endemic areas may carry large
numbers of infected ticks thus spreading the CCHF virus into novel areas. From 2000 through
2008, the infection emerged or re-emerged in Bulgaria, Albania, Kosovo, and Turkey. It has also
recently emerged in Greece, where the first human case has been recognized. This has been
attributed to mild winters and to the disruption of agricultural activities, both accounting for an
increased tick population, as well as to the migration or transportation of tick-infested birds or
animals. CCHF cases occurring as an expected event in endemic areas should be notified to
clinicians in the international neighborhood. They should be aware of the probability of
importation of CCHF cases from endemic areas, of human-to-human transmission, particularly
in the nosocomial setting, and of the potential transmission of the virus via tick-infested and
infected imported livestock. This novel European CCHF geographic distribution is a challenge for
the scientific community of medical microbiologists, epidemiologists, medical entomologists, and
veterinarians that could be followed by acceleration of a European Standardized Response at the
national, regional, and international level.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction and epidemiology
Crimean-Congo hemorrhagic fever (CCHF) is an acute, tick-
borne viral disease, affecting only humans and newborn
mice,1 with hemorrhagic manifestations and considerable
mortality in humans.* Tel.: +30 210 52 12 000; fax: +30 6976 17 80 74.
E-mail address: vorou@keelpno.gr.
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doi:10.1016/j.ijid.2009.03.028CCHF virus circulates in nature in an enzootic tick—
vertebrate—tick cycle, the ticks of the genus Hyalomma
serving as vectors and reservoirs of the virus1—4 and defining
the worldwide distribution of the CCHF virus.1,2,5,6 Viremia
or antibody production has been demonstrated in numerous
domestic and wild vertebrates that suffer an asymptomatic
infection,1,5,7,8 while reptiles and birds appear to be refrac-
tory to infection with the exception of ostriches.1 Small
herbivores are infested by the nymphal stages of ticks,
which transmit the virus transstadially.2 Migrating birds
may carry large numbers of infected ticks, thus spreadingPublished by Elsevier Ltd. All rights reserved.
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endemic to non-endemic areas may be infested with
infected ticks.8—12
Close contact with viremic animals is the second most
frequent route of transmission after tick bite.1,2 Healthcare
worker contact with a patient, nosocomial contact of a
secondary patient with the index patient,13 family contact,
and breastfeeding have been reported as modes of transmis-
sion.14
CCHF virus is endemic in parts of Eurasia and Africa, and
demonstrates the widest distribution, in an ever-extending
range of geographic areas, among all the tick-borne
viruses.1—5,7,9,15—17
Southeastern Europe depicts a rapidly
changing epidemiology of CCHF
From 2000 through 2008 a considerable number of out-
breaks in the community and the nosocomial setting were
reported18 in southeastern Europe; in Bulgaria in 2002,
2003,17 and 2008,19 and in Albania and Kosovo in 2001,
with as yet undefined reservoirs.17,20,21 Social disruption,
conflict, and war have been the major factors identi-
fied.17,20—22
Similarly to Kenya, Senegal, and South Africa, the 2002
outbreak in Northeastern Anatolia, Turkey, an eastern
Black Sea extended geographic region,14 followed several
decades of serologic evidence of a zoonotic focus,1,3,5,16,23
not preceded by any human case in the country.14 In 2007
and 2008 a considerable number of CCHF confirmed cases
occurred in southeastern and western areas of Turkey,
which in 2008 contributed 9% of cases.24 The infection
has spread to previously non-endemic areas of Turkey, near
the Aegean coast of the country and in a rural area of
Ankara.13
There is serologic evidence, but not clinical evidence as
yet, in France, Portugal, and Hungary.1—3
In northern Greece the appearance of a fatal human case
in June 2008, the first ever reported in Greece, followed
serological evidence attributed to the non-pathogenic
AP92.25 It is not feasible to speculate whether this was
associated with the cases in Bulgaria in March 2008, as
retrospective surveys jointly coordinated by public health
and veterinary public health sectors are pending.
Climate change and/or socioeconomic factors
increase the incidence
In temperate areas, the pattern of seasonality of CCHF
cases reflects the period of year with high tick activity—
between spring and early autumn.17,20,21 Climate and
environmental changes may trigger community out-
breaks.3,7 Mild winters were followed by CCHF outbreaks
in Kosovo in 2001 and in Turkey in 2004.3,20 Disruption of
agricultural activities and expansion of the hare population
infested with infected ticks, followed by the reintroduc-
tion of cattle and sheep, have been associated with the
CCHF outbreaks in the former Soviet Union, Bulgaria,
Kosovo, and in the Middle Anatolia Turkish areas.3 Illegal
animal transportation accounts for the expansion of the
disease.22International dissemination of reports of
cases within endemic areas increases
awareness among neighbor countries
Legal and potentially illegal animal
transportation among neighboring countries
Animal transportation imposes a risk of international spread
from endemicwell-prepared countries to non-endemic unpre-
pared ones.22 Consequently, even if the CCHF cases occur as a
usual or expected event in endemic areas, notification of CCHF
cases as a public health emergency of international concern is
deemed imperative. Both the InternationalHealthRegulations
and the Early Warning and Response System are competent
tools for the dissemination of this information.
National centers for disease control and
prevention should increase physician awareness
Physicians should be aware of the probability of importation
of CCHF cases from endemic areas, of human-to-human
transmission, particularly in the nosocomial setting, and of
the potential transmission of the virus via tick-infested and
infected imported animals. Prompt suspicion and diagnosis
trigger the timely implementation of infection control mea-
sures in the community and the hospital.
At this point, the role of the national centers for disease
control and prevention is crucial, as they may generate and
disseminate warnings and the relevant diagnostic and ther-
apeutic approach to clinicians soon after the emergence or
re-emergence of CCHF in the international neighborhood of
each distinct country.
Therapeutic consensus
The administration of ribavirin, oral or intravenous, is recom-
mended by the World Health Organization26 and it has been
associated with higher survival rates, shorter recovery time,
and earlier return to normal levels of laboratory para-
meters.27 Replacement therapy with blood products, accord-
ing to the results of the complete blood count, is
indispensable in the management of severe CCHF cases.
Treatment with ribavirin in suspected cases28 and post-
exposure prophylaxis for healthcare workers potentially
exposed to CCHF virus29 should be considered.
Coordinated actions of the public health
sector with the veterinarian authorities
ensure preparedness and response
Experts from all relevant disciplines, experienced medical
microbiologists, epidemiologists, medical entomologists, and
veterinarians, should reach a consensus regarding yearly mon-
itoring before the active period from March through October.
Empowerment of the veterinary sector
Farmers and animal husbandry workers, who might handle
animals imported from the endemic areas of neighboring
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in a non-endemic country. They should be made aware of the
need to consult with the local veterinary authorities, and if
indicated the need to conduct serologic examinations on the
imported animals, especially those with an evident tick
infestation.
Veterinary inspections and the accompanying strict
recommendations could also prevent any illegal animal trans-
portation among countries so as to reduce the probability of
cross-border spread of infected ticks and subsequent expan-
sion of CCHF. The empowerment of the veterinary sector
throughout southeastern Europe and the enhancement of
their cooperation and rapid information sharing with the
human public health sector at the local, national, regional,
and international level are highly recommended.
In endemic areas, professional groups in contact with
animals should be educated to take precautions against
contact with ticks and blood or other tissues: the wearing
of gloves, use of long trousers and long sleeves if possible, the
application of repellents on exposed skin, and the thorough
inspection of skin and clothes for ticks.
Veterinarians should be trained to convey their knowledge
of CCHF epidemiology,mode of transmission, and particularly
precautions to farmers of backyard cattle or other animals.
They should conduct consultation meetings and guide rural
populations on how to minimize the likelihood of acquiring
any zoonoses including CCHF, in close collaboration with the
public health sector.
Environmental interventions
Free-range areas should be clearly oriented and accurately
differentiated from residential and tourist areas.
Regular agricultural activities to keep farms neat and tick
control measures protect domestic animals from ticks and
tick-borne diseases.19
Animal serologic surveys and medical
entomologists are capable of detecting virus
circulation early
Serology of imported animals is an important subsidiary to
consistent strict measures against illegal animal cross-border
trafficking.
Medical entomology has a vital role in the characterization
of tick species according to international taxonomy, and
medical microbiology in the examination of pooled samples
of ticks for the CCHF virus RNA.
Conclusions
Monitoring of the virus circulation in probable zoonotic foci is
of paramount importance in the temperate countries of
southern Europe, where there are densely populated coastal
areas, many of which are also major tourist destinations.
Early virus detection in ticks, large herbivores, and small
mammals, particularly when they originate from endemic
areas of the same or a neighboring country, is the cornerstone
of prevention of human cases. Periodic education of high risk
groups by those in the veterinary and public health sectors
and regular updating of clinicians also play an important rolein the early diagnosis of cases and in the prevention of
establishment of the virus in novel areas and the subsequent
outbreaks. This will also contribute to the containment and
elimination of the disease in already endemic areas.
Under intense media and public interest or even in the
panic that CCHF emergence generates, there may be unrea-
sonable allocation of resources and an increased economic
burden for tourism and the farming industry of a country. The
cross-border transmission of CCHF virus via legal or illegal
animal movement should be prevented via strict veterinary
monitoring.
The novel European CCHF geographic distribution is a
challenge for the scientific community that could be followed
by acceleration of a European Standardized Response at the
national, regional, and international level.
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